Company Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services.
Further, it engages in the provision of inpatient dialysis services and related laboratory services; and transplant software business.
The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016.
DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
| Country | United States |
| Founded | 1994 |
| IPO Date | Oct 31, 1995 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 76,000 |
| CEO | Javier Rodriguez |
Contact Details
Address: 2000 16th Street Denver, Colorado 80202 United States | |
| Phone | 720-631-2100 |
| Website | davita.com |
Stock Details
| Ticker Symbol | DVA |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000927066 |
| CUSIP Number | 23918K108 |
| ISIN Number | US23918K1088 |
| Employer ID | 51-0354549 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Javier J. Rodriguez | Chief Executive Officer and Executive Director |
| Joel Ackerman | Chief Financial Officer and Treasurer |
| Christopher Michael Berry CPA | Group Vice President and Chief Accounting Officer |
| Madhu Narasimhan | Chief Information Officer |
| Nic Eliason | Group Vice President of Investor Relations |
| Jessica Hergenreter | Chief People Officer |
| Misha Palecek | Chief Transformation Officer of U.S. Kidney Care Business |
| Dr. Jeffrey Allen Giullian | Chief Medical Officer of Kidney Care |
| Dr. Partha Das M.D., M.Sc. | Chief Medical Officer of DaVita International |
| Mandy Hale | Chief Nursing Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 25, 2025 | SCHEDULE 13G/A | Filing |
| Apr 24, 2025 | ARS | Filing |
| Apr 24, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 24, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 14, 2025 | 8-K | Current Report |
| Feb 13, 2025 | SCHEDULE 13D/A | Filing |
| Feb 13, 2025 | 10-K | Annual Report |
| Feb 13, 2025 | 8-K | Current Report |
| Nov 27, 2024 | 144 | Filing |
| Nov 18, 2024 | 144 | Filing |